Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LIPG | Q9Y5X9 | 15/20 | 0.43 |
| ▸ | LIPC | P11150 | 1/20 | 0.33 |
| ▸ | GPR55 | Q9Y2T6 | 2/20 | 0.33 |
| ▸ | CNR2 | P34972 | 1/20 | 0.32 |
| ▸ | BRAF | P15056 | 1/20 | 0.32 |
| ▸ | MAP2K1 | Q02750 | 1/20 | 0.32 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14259602 | 0.81 | LIPG (0.47) | LIPGLIPCGPR55CNR2 | |
| SCHEMBL755390 | 0.80 | LIPG (0.46) | LIPGLIPC | |
| SCHEMBL754651 | 0.80 | LIPG (0.45) | LIPGMAPT | |
| SCHEMBL754957 | 0.78 | LIPG (0.49) | LIPGLIPC | |
| SCHEMBL752899 | 0.75 | LIPG (0.51) | LIPGLIPC | |
| SCHEMBL6811177 | 0.73 | LIPG (0.55) | LIPGMAPT | |
| SCHEMBL754256 | 0.73 | LIPG (0.49) | LIPGLIPC | |
| SCHEMBL2777764 | 0.72 | LIPG (0.48) | LIPGLIPC | |
| SCHEMBL752680 | 0.72 | LIPG (0.46) | LIPGLIPC | |
| SCHEMBL2778238 | 0.72 | LIPG (0.47) | LIPGLIPC |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170066754-A1 | ANTIVIRAL AGENT | SHIONOGI & CO., LTD. (JP) | 2017-03-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170066754-A1 | ANTIVIRAL AGENT | ZC3HAV1, ZC3HAV1L, CCNI | LIPG 4229/4885LIPC 3817/4885GPR55 2647/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.